WO2010050583A1 - 抗ヘリコバクター・ピロリ活性剤 - Google Patents
抗ヘリコバクター・ピロリ活性剤 Download PDFInfo
- Publication number
- WO2010050583A1 WO2010050583A1 PCT/JP2009/068668 JP2009068668W WO2010050583A1 WO 2010050583 A1 WO2010050583 A1 WO 2010050583A1 JP 2009068668 W JP2009068668 W JP 2009068668W WO 2010050583 A1 WO2010050583 A1 WO 2010050583A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- helicobacter pylori
- extract
- activity
- agent
- activator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to Helicobacter pylori involved in the development of peptic ulcer.
- the present invention relates to an anti-Helicobacter pylori activator that can effectively sterilize and eliminate Helicobacter pylori.
- Helicobacter pylori (hereinafter also referred to as Helicobacter pylori) is one of Gram-negative bacillus (Racillus) and has several edge flagella. Since this flagella rotates and moves, the name of Helicobacter (rotating fungus) is given. What is characteristic is that it can survive in the highly acidic environment of the human stomach, and as the name of H. pylori shows, it mainly infects the pylorus of the stomach.
- the present invention provides an anti-Helicobacter pylori activator useful for the treatment, prevention or amelioration of diseases related to Helicobacter pylori.
- the present inventors have found that an extract of Lamiaceae plants can effectively suppress the growth of Helicobacter pylori, and have completed the present invention.
- the present invention provides the following: 1. An anti-Helicobacter pylori activator comprising an extract of a Labiatae plant as an active ingredient, 2. The anti-Helicobacter pylori activator according to 1 above, wherein the Labiatae plant is Naginata Kouji, Aojiso, 3. The anti-Helicobacter pylori activator according to 1 above, wherein the Labiatae plant is Yahashi, 4). The anti-Helicobacter pylori activator according to any one of 1 to 3 above, wherein the extract contains a fraction that has passed through a molecular weight cutoff filter of 5,000, 5).
- a method for sterilizing Helicobacter pylori comprising eating and drinking the anti-Helicobacter pylori activator according to any one of 1 to 5 above, 6).
- the anti-Helicobacter pylori activator of the present invention has an excellent growth inhibitory action, sterilization and sterilization action against Helicobacter pylori, and is highly safe.
- the anti-Helicobacter pylori activator of the present invention has excellent thermal stability. Furthermore, the anti-Helicobacter pylori activator of the present invention can obtain a sterilizing effect in a short period of time. Therefore, it is very useful for the eradication of Helicobacter pylori and the treatment, prevention or improvement of diseases related to Helicobacter pylori.
- the anti-Helicobacter pylori activator means a composition capable of suppressing the growth of Helicobacter pylori.
- Such an anti-Helicobacter pylori activator can remove Helicobacter pylori from the stomach
- the anti-Helicobacter pylori activator of the present invention is a disease related to Helicobacter pylori, more specifically, gastric ulcer and It can be used for the treatment, prevention or improvement of peptic ulcer such as duodenal ulcer, gastritis (acute gastritis, atrophic gastritis), gastric MALT lymphoma and gastric cancer.
- the Lamiaceae plant can be any plant as long as it belongs to the family Lamiaceae, but is preferably a plant belonging to the genus Elsholtzia, more Preferable examples are Elsholtzia ciliata, Perilla frutescens viridis, and Yahashi (Elsholtzia regulosa). Naginata Koju is used as a herbal medicine. Aojiso is also widely used for food. Yahashi is commonly used as tea in China. Therefore, these extracts are highly safe and can be used for a long time.
- Dry products of Labiatae plants such as Naginata Koju and Aojiso are commercially available and can be used in the present invention.
- Yahashi for example, can be used that is native to Yunnan, China.
- the Labiatae plant used in the present invention may be in a raw state after collection or in a dried state.
- Examples of the site include mature or immature flowers, fruit, pericarp, seeds, leaves, petiole, branches, roots and the like. A flower spike is preferred.
- Extraction can be performed by a conventional extraction method, for example, by extracting an active ingredient from a plant raw material with an extraction solvent.
- the plant material may be extracted after being pulverized.
- a pulverization method a conventional method can be applied. For example, pulverization is performed using a mortar, an atomizer, a hammer mill, a stamp mill, a ball mill, or the like.
- the extraction solvent examples include water; alcohols such as methanol, ethanol, isopropanol, t-butanol, octanol, or 2-methyl-4-phenylbutanol; ketones such as acetone, methyl isobutyl ketone, acetophenone, or benzophenone.
- Esters such as ethyl acetate, butyl acetate, methyl benzoate or t-butyl benzoate; hydrocarbons such as hexane, heptane, octane, decane, undecane, dodecane, cyclohexane or decalin; phosphate buffer Buffer solutions such as physiological saline (PBS); or mixtures thereof.
- PBS physiological saline
- water, methanol, ethanol, hexane, ethyl acetate, acetone, phosphate buffered saline (PBS), or a mixture thereof is used.
- a mixed solvent of water and a hydrophilic solvent can also be used as the extraction solvent.
- the ratio of water to the hydrophilic solvent can be appropriately selected from a wide range.
- water: hydrophilic solvent 95: 5 to 5:95, preferably 50:50 to 10:90.
- a 50% ethanol aqueous solution can be used.
- Extraction is performed, for example, using 0.1 part by weight to 10,000 parts by weight, preferably 1 part by weight to 100 parts by weight of the solvent with respect to 1 part by weight of the plant body.
- the extraction temperature is not particularly limited, but is preferably 0 ° C. to 100 ° C., and more preferably 20 ° C. to 90 ° C.
- the extraction time is not particularly limited, but is preferably, for example, 1 minute to 1 week, and more preferably 30 minutes to 1 day.
- the extract can be processed by various solid-liquid separation methods such as sedimentation separation, cake filtration, clarification filtration, centrifugal filtration, centrifugal sedimentation, press separation, and filter press.
- the extract may be used after passing through a filter that cuts off a certain molecular weight.
- a fraction passing through a filter having a molecular weight of 20,000 can be preferably used, and a fraction passing through a filter having a molecular weight of 5,000 can be more preferably used.
- the extract extracted with the extraction solvent may be used as it is, or diluted or concentrated. Alternatively, it may be pulverized by a method such as freeze drying or spray drying.
- the amount of the extract used may be an effective amount that exhibits antibacterial activity against Helicobacter pylori, for example, per extract unit or per adult day, in terms of extract extract About 0.01 to 10.0 g, and about 0.1 mg to 5.0 g in terms of dry extract.
- the concentration of the extract in the preparation varies depending on the form, but in the case of solid forms such as tablets (tablets), chewable tablets, granules, capsules (eg, hard capsules), the concentration is 0.01% relative to the total mass. It is in the range of -100% by weight, preferably 10-100% by weight.
- the final concentration of the active ingredient in the stomach is adjusted to 10 to 100 ⁇ g / ml.
- the forms of the anti-Helicobacter pylori active agent of the present invention include various forms such as solid foods such as tablets (tablets), chewable tablets, granules, capsules (for example, hard capsules) and liquid foods, as well as soups, juices and teas.
- solid foods such as tablets (tablets), chewable tablets, granules, capsules (for example, hard capsules) and liquid foods, as well as soups, juices and teas.
- the anti-Helicobacter pylori activator of the present invention can also be used as a health food or a medical food, and the form is not particularly limited, but in addition to tablets (tablets), chewable tablets, granules, capsules, etc. It is preferable to make it a form that can be continuously ingested, such as foods, soups, beverages, and liquid foods.
- the anti-Helicobacter pylori activator of the present invention includes various food additives such as various nutrients, various vitamins, minerals, dietary fiber, polyunsaturated fatty acids, stabilizers such as dispersants and emulsifiers, sweeteners, Taste ingredients, flavors, etc. can be blended.
- various food additives such as various nutrients, various vitamins, minerals, dietary fiber, polyunsaturated fatty acids, stabilizers such as dispersants and emulsifiers, sweeteners, Taste ingredients, flavors, etc. can be blended.
- a liquid it may be prepared as a liquid from the beginning, but it may be prepared in a powder or paste form and dissolved in a predetermined amount of an aqueous liquid.
- the anti-Helicobacter pylori activator of the present invention can be used by adding to any food material, for example, milk, fruit juices such as orange and lemon, dairy products such as yogurt, bread and other foods.
- the anti-Helicobacter pylori activator of the present invention has excellent thermal stability. Therefore, even when added to the food and heated, the activity can be maintained.
- the anti-Helicobacter pylori activator of the present invention can remove Helicobacter pylori in the gastrointestinal tract, it can be used to treat, prevent or ameliorate diseases related to Helicobacter pylori.
- Diseases associated with Helicobacter pylori include those caused by the presence of Helicobacter pylori in the gastrointestinal tract. Specific examples include peptic ulcers such as gastric ulcer and duodenal ulcer, gastritis (acute gastritis, atrophic gastritis), gastric MALT lymphoma, gastric cancer, etc. (Helocobacter pylori infection diagnosis and treatment guidelines (revised edition), Japan Helicobacter Society, 2003). In June 2000, the Japan Helicobacter Society recommended that "Guidelines for diagnosis and treatment were published and that" all Helicobacter pylori-positive gastric ulcers and duodenal ulcers are indicated for sterilization treatment ".
- Example 1 Preparation of Extract Extract As a Lamiaceae plant, Yahashi, Naginata Kouji, Aojiso were used.
- Yahashi (Elsholtzia regulosa) was collected from Otomo, Yunnan, China, and dried plants (including flower spikes) were used.
- Elsholtzia ciliata used a commercial product of finely chopped dried whole plant (Nyakugawa Kampo Pharmacy, Neyagawa City).
- Aojiso Pier frutescens viridis was used by drying commercially available spikelets and leaves.
- Extraction was performed by stirring overnight at 4 ° C. using 30 ml of extraction solvent for 1 g of dry powder obtained by grinding dry grass in a mortar.
- As the extraction solvent PBS, 50% ethanol, and 100% methanol were used. This was centrifuged at 4,000 rpm for 30 minutes, and the supernatant was collected.
- a specimen extracted with 50% ethanol or 100% methanol was used by dissolving a dry powder obtained by evaporating alcohol in a predetermined amount of PBS and filtering it with a Millipore membrane. The PBS extract was used as it was or after being concentrated and filtered as necessary.
- Test Example 1 Measurement of anti-Helicobacter pylori activity
- the measurement of anti-Helicobacter pylori activity was carried out by a paper disc method using Viril bacteria culture agar medium (Poremedia Vi HELICO AGAR, Eiken Chemical). After the entire surface was coated with Helicobacter pylori on this medium, a thick circular paper (ADVANTEC) 8 mm in diameter soaked with 60 ⁇ l of the extract was placed thereon and cultured under 10% carbon dioxide gas. After 3 to 4 days of culture, the size of the Helicobacter pylori growth inhibition zone formed around the paper was observed. Chloramfufenicol (CM, 100 ⁇ g / ml) was placed as a positive control, and solvent PBS was placed as a negative control.
- CM Chloramfufenicol
- the minimum inhibitory concentration (MIC) of chloramphenicol according to the present method is about 5 ⁇ g / ml
- the minimum inhibitory concentration (MIC) of Helicobacter pylori in the Yahashi spikelet extract is 1 / 20 and was 0.25 ⁇ g / ml.
- the 50% ethanol extract of Yahashi Kaho had stronger anti-Helicobacter pylori activity than the PBS extract.
- the extract obtained by further extracting the residue after the extraction of Yahashi Kaho with PBS with a 50% aqueous ethanol solution has a stronger anti-Helicobacter pylori activity.
- Test Example 2 Heat stability of anti-Helicobacter pylori activity
- PBS extract of Yahashi Koho 50% ethanol extract of Naginata Koju
- Anti-Helicobacter pylori activity after heating (boiling) the PBS extract at 100 ° C. for 20 minutes was examined. The measurement was performed in the same manner as in Test Example 1 above.
- the heat-treated extract maintained almost the same level of anti-Helicobacter pylori activity as the extract before the heat treatment.
- Test Example 3 Examination of molecular size of substance having anti-Helicobacter pylori activity The molecular size of the antibacterial substance contained in the extract was examined. Yahashi's PBS extract, Naginata Koju's 50% ethanol extract and Aojiso's PBS extract were used, which were respectively 30,000, 20,000, 10,000, The antibacterial activity was measured by passing through a 5,000 molecular weight cut filter. The measurement was performed in the same manner as in Test Example 1 above.
- Test Example 4 Search for Anti-Helicobacter pylori Active Ingredients of Yahashi Using an extract extracted from Yahashi Kaho with 100% methanol, an attempt was made to separate and purify antibacterial substances. First, a 100% methanol extract of Yahashi Kaho was concentrated and then extracted with hexane, ethyl acetate, and PBS, respectively, using partition chromatography. Among these extracts, strong antibacterial activity was observed in hexane and ethyl acetate fractions. Next, the ethyl acetate fraction that showed particularly strong activity was further applied to a silica gel cartridge column.
- the anti-Helicobacter pylori activator according to the present invention has an excellent growth inhibitory action, sterilization and sterilization action against Helicobacter pylori, and has an excellent thermal stability.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
(Helicobacter pylori)を効果的に除菌・排菌することができる、抗ヘリコバクター・ピロリ活性剤に関する。
1.シソ科植物の抽出物を有効成分として含む、抗ヘリコバクター・ピロリ活性剤、
2.シソ科植物が、ナギナタコウジュ、アオジソである、上記1に記載の抗ヘリコバクター・ピロリ活性剤、
3.シソ科植物が、ヤハシである、上記1に記載の抗ヘリコバクター・ピロリ活性剤、
4.抽出物が、5,000の分子量カットオフフィルターを通過した画分を含む、上記1~3のいずれかに記載の抗ヘリコバクター・ピロリ活性剤、
5.ヘリコバクター・ピロリに関連する疾患の治療、予防または改善に用いる、上記1~4のいずれかに記載の抗ヘリコバクター・ピロリ活性剤、
6.上記1~5のいずれかに記載の抗ヘリコバクター・ピロリ活性剤を飲食することからなる、ヘリコバクター・ピロリの除菌方法、
6.シソ科植物の抽出物を含む、ヘリコバクター・ピロリ除菌のための食品添加用組成物、
に関する。
10:90である。例えば、50%エタノール水溶液を用いることができる。
シソ科植物として、ヤハシ、ナギナタコウジュ、アオジソを用いた。ヤハシ(Elsholtzia regulosa)は、中国雲南省大桃で採取され、乾燥した植物体(花穂を含む)を用いた。ナギナタコウジュ(Elsholtzia ciliata)は、乾燥させた花期の全草を細かく刻んだ市販品を使用した(百花園漢方薬局、寝屋川市)。アオジソ(Perilla frutescens viridis)は、市販されている花穂および葉を乾燥させて用いた。
抗ヘリコバクター・ピロリ活性の測定は、ビロリ菌培養寒天培地(ポアメディアVi HELICO AGAR、栄研化学)を用いたペーパーディスク法により行った。この培地にヘリコバクター・ピロリを全面塗布したのち、その上に60μlの抽出液をしみ込ませた直径8mmの厚手の円形ロ紙(ADVANTEC)を置き、10%炭酸ガス下で培養を行った。培養3~4日後に、ロ紙の周囲に形成されるヘリコバクター・ピロリ増殖阻止帯の大きさを観察した。陽性対照としてクロラムフフェニコール(CM、100μg/ml)を置き、陰性対照として溶媒であるPBSを置いた。
(1)ヤハシ抽出物
ヤハシ花穂のPBS抽出液は、強い抗ヘリコバクター・ピロリ活性があることが認められた。ヘリコバクター・ピロリの発育阻止域の大きさで判断して、ヤハシ花穂抽出液の抗ヘリコバクター・ピロリ活性は、クロラムフェニコールの100μg/ml濃度にほぼ相当する強さであった。クロラムフェニコールによる抗菌活性は5μg/ml濃度でほぼ認められなくなった。本法によるクロラムフェニコールの最小発育阻止濃度(MIC)を
5μg/ml程度と仮定すると、ヤハシ花穂抽出液のヘリコバクター・ピロリに対する最小発育阻止濃度(MIC)は、クロラムフェニコールに対し1/20であり、0.25μg/mlであった。
さらに、ヤハシ花穂の50%エタノール抽出液は、PBS抽出液より強い抗ヘリコバクター・ピロリ活性があった。また、ヤハシ花穂のPBS抽出を行った後の残渣をさらに50%エタノール水溶液で抽出した抽出液は、さらに強い抗ヘリコバクター・ピロリ活性を有することが認められた。
(2)ナギナタコウジュ抽出物
ナギナタコウジュ全草のPBS抽出液は、5倍濃縮液で明らかな抗ヘリコバクター・ピロリ活性が確認された。また、ナギナタコウジュ全草の50%エタノール抽出液および100%メタノール抽出液は、PBS抽出液より強い抗ヘリコバクター・ピロリ活性があった。
(3)アオジソ抽出物
アオジソ花穂のPBS抽出液には、濃縮することなしに強い抗ヘリコバクター・ピロリ活性が認められた。このアオジソ花穂PBS抽出液の抗ヘリコバクター・ピロリ活性は、クロラムフェニコールの100μg/ml濃度の活性を上回った。また、アオジソ花穂の50%エタノール抽出液は、PBS抽出液と同等の抗ヘリコバクター・ピロリ活性を有することが認められた。
抗ヘリコバクター・ピロリ活性を有する物質の熱安定性を検討するために、ヤハシ花穂のPBS抽出液、ナギナタコウジュの50%エタノール抽出液、およびアオジソ花穂のPBS抽出液を100℃で20分間加熱(煮沸)処理した後の抗ヘリコバクター・ピロリ活性を検討した。測定は、上記試験例1と同様の方法で行った。
いずれの抽出液において、加熱処理をした抽出液は、加熱処理前の抽出液とほぼ同程度の抗ヘリコバクター・ピロリ活性を維持した。
抽出液に含まれる抗菌物質の分子サイズを検討した。ヤハシのPBS抽出液、ナギナタコウジュ花穂の50%エタノール抽出液、アオジソのPBS抽出液を用い、これらを各々30,000、20,000、10,000、
5,000の分子量カットフィルターを通過させ、その抗菌活性を測定した。測定は、上記試験例1と同様の方法で行った。
いずれの抽出液において、分子量5,000以下の画分に強い抗ヘリコバクター・ピロリ活性が認められた。アオジソのPBS抽出液においては、分子量5,000を超える画分には抗ヘリコバクター・ピロリ活性が認められなかった。
ヤハシ花穂から100%メタノールで抽出した抽出液を用い、抗菌物質の分離・精製を試みた。先ず、ヤハシ花穂の100%メタノール抽出液を濃縮後、分配クロマトグラフィーを用いて、各々ヘキサン、酢酸エチル、PBSで抽出した。これら抽出液のうち、強い抗菌活性が認められたのはヘキサン、酢酸エチル画分であった。次に、特に強い活性を示した酢酸エチル画分をさらにシリカゲルカートリッジカラムにかけた。クロロホルム・メタノール溶液で溶出されたフラクションA1~A10(Fr.A1-Fr.A10)のうち、Fr.A5とFr.A10(クロロホルム:メタノール=4:1)に抗菌活性が認められた。この2画分を集め、さらにODSカートリッジカラムでメタノール抽出を行った。活性の認められたフラクションB1(Fr.B1)を分取用HPLCカラムで精製し、得られたフラクションC1~C99(Fr.C1-Fr.C99)について検討したところ、Fr.C10-C12に抗菌活性が認められた。これらの分離・精製の結果から、抗ピロリ菌物質は、ヘキサンや酢酸エチルのような有機溶媒によって容易に抽出される極性の高い疎水性物質であると判断された。
Claims (7)
- シソ科植物の抽出物を有効成分として含む、抗ヘリコバクター・ピロリ活性剤。
- シソ科植物が、ナギナタコウジュ、アオジソである、請求項1に記載の抗ヘリコバクター・ピロリ活性剤。
- シソ科植物が、ヤハシである、請求項1に記載の抗ヘリコバクター・ピロリ活性剤。
- 抽出物が、5,000の分子量カットオフフィルターを通過した画分を含む、請求項1~3のいずれかに記載の抗ヘリコバクター・ピロリ活性剤。
- ヘリコバクター・ピロリに関連する疾患の治療、予防または改善に用いる、請求項1~4のいずれかに記載の抗ヘリコバクター・ピロリ活性剤。
- 請求項1~5のいずれかに記載の抗ヘリコバクター・ピロリ活性剤を飲食することからなる、ヘリコバクター・ピロリの除菌方法。
- シソ科植物の抽出物を含む、ヘリコバクター・ピロリ除菌のための食品添加用組成物。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200980143318.2A CN102215852B (zh) | 2008-10-30 | 2009-10-30 | 抗幽门螺杆菌活性剂 |
| JP2010535847A JP5600067B2 (ja) | 2008-10-30 | 2009-10-30 | 抗ヘリコバクター・ピロリ活性剤 |
| EP09823693.8A EP2351572B1 (en) | 2008-10-30 | 2009-10-30 | Agent having anti-helicobacter pylori activity |
| US13/126,770 US8658226B2 (en) | 2008-10-30 | 2009-10-30 | Agent having anti-Helicobacter pylori activity |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008279358 | 2008-10-30 | ||
| JP2008-279358 | 2008-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2010050583A1 true WO2010050583A1 (ja) | 2010-05-06 |
Family
ID=42128942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2009/068668 Ceased WO2010050583A1 (ja) | 2008-10-30 | 2009-10-30 | 抗ヘリコバクター・ピロリ活性剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8658226B2 (ja) |
| EP (1) | EP2351572B1 (ja) |
| JP (1) | JP5600067B2 (ja) |
| CN (1) | CN102215852B (ja) |
| WO (1) | WO2010050583A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016029897A (ja) * | 2014-07-25 | 2016-03-07 | 木村 由美子 | しそ飲料の製造方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL245199B1 (pl) * | 2018-04-13 | 2024-06-03 | Osrodek Badawczo Produkcyjny Politechniki Lodzkiej Ichem Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja do zastosowania do wspomagania odporności organizmu w profilaktyce i leczeniu zakażeń Helicobacter pylori |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH115745A (ja) * | 1997-06-13 | 1999-01-12 | Agency Of Ind Science & Technol | 抗hiv活性物質およびその製造方法 |
| JP2001270835A (ja) * | 2000-03-15 | 2001-10-02 | Korea Yakult Co Ltd | 胃潰瘍の予防及び治療に効果的な蘇葉抽出物とその用途及びその抽出物からベルベリンを得る工程 |
| JP2003252776A (ja) * | 2002-02-27 | 2003-09-10 | Wakunaga Pharmaceut Co Ltd | キサンチンオキシダーゼ阻害剤 |
| WO2008133098A1 (ja) * | 2007-04-16 | 2008-11-06 | Kikuji Yamaguchi | ヘリコバクター・ピロリ除菌剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2442633A1 (fr) * | 1978-11-28 | 1980-06-27 | Kitasato Inst | Inducteurs d'interferon et leur procede de fabrication |
| JPS5978646A (ja) * | 1982-10-25 | 1984-05-07 | Shoichi Ando | 抹茶 |
| JPS60237961A (ja) * | 1984-05-10 | 1985-11-26 | Iwasaki Shokuhin Kogyo:Kk | 特殊麺汁の製造法 |
| JPS63207360A (ja) * | 1987-02-24 | 1988-08-26 | Masato Komachi | うにみその製法 |
| JPH04158737A (ja) * | 1990-10-19 | 1992-06-01 | Kazumi Chiba | 生青ジソに復元可能な乾燥青ジソの製造方法 |
| JPH06133744A (ja) * | 1992-10-27 | 1994-05-17 | Sumiko Sawabe | はとむぎ健康茶及びその製造方法 |
| JP3547782B2 (ja) * | 1993-12-28 | 2004-07-28 | ロート製薬株式会社 | 抗ヘリコバクター・ピロリ活性剤 |
| JPH08295632A (ja) * | 1995-03-02 | 1996-11-12 | Takeda Chem Ind Ltd | 抗菌剤 |
| EP0821967A1 (en) * | 1996-08-02 | 1998-02-04 | Institute For Advanced Skin Research Inc. | Composition for enhancing hyaluronic acid productivity and method for preparing same |
| JP3047100B2 (ja) * | 1997-09-04 | 2000-05-29 | 有限会社吉川農園 | 青臭みのないシソジュースの製造方法 |
| US20010024664A1 (en) * | 1999-03-19 | 2001-09-27 | Obukowicz Mark G. | Selective COX-2 inhibition from edible plant extracts |
| JP2002262811A (ja) * | 2001-03-08 | 2002-09-17 | Emiko Watanabe | 梅干しと植物入り豆腐、厚揚げ |
| KR20070091391A (ko) * | 2006-03-06 | 2007-09-11 | 권태국 | 기능성 발효 버블음료 |
| JP3977724B2 (ja) * | 2001-11-06 | 2007-09-19 | ロート製薬株式会社 | 医薬組成物 |
| KR100496146B1 (ko) * | 2002-06-12 | 2005-06-20 | 주식회사 뉴로넥스 | 감초, 강황 및 소엽의 추출물을 함유한 위염 및 위궤양의예방 및 치료를 위한 조성물 |
| JP2006223143A (ja) * | 2005-02-16 | 2006-08-31 | Kyoei:Kk | 香気性苦汁組成物 |
| WO2007007958A1 (en) * | 2005-07-08 | 2007-01-18 | Yuhan Corporation | Herbal pharmaceutical composition for regenerative agent of cartilaginous tissue and treatment of osteoarthritis |
| CN1785238A (zh) * | 2005-09-30 | 2006-06-14 | 昆明金殿制药有限公司 | 鸡肝散提取物总黄酮在制备抗炎药物中的应用 |
| TWI449786B (zh) * | 2007-06-14 | 2014-08-21 | Suntory Holdings Ltd | Safflower and natural aroma of distilled liquor and its manufacturing method |
-
2009
- 2009-10-30 US US13/126,770 patent/US8658226B2/en active Active
- 2009-10-30 WO PCT/JP2009/068668 patent/WO2010050583A1/ja not_active Ceased
- 2009-10-30 EP EP09823693.8A patent/EP2351572B1/en not_active Not-in-force
- 2009-10-30 JP JP2010535847A patent/JP5600067B2/ja not_active Expired - Fee Related
- 2009-10-30 CN CN200980143318.2A patent/CN102215852B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH115745A (ja) * | 1997-06-13 | 1999-01-12 | Agency Of Ind Science & Technol | 抗hiv活性物質およびその製造方法 |
| JP2001270835A (ja) * | 2000-03-15 | 2001-10-02 | Korea Yakult Co Ltd | 胃潰瘍の予防及び治療に効果的な蘇葉抽出物とその用途及びその抽出物からベルベリンを得る工程 |
| JP2003252776A (ja) * | 2002-02-27 | 2003-09-10 | Wakunaga Pharmaceut Co Ltd | キサンチンオキシダーゼ阻害剤 |
| WO2008133098A1 (ja) * | 2007-04-16 | 2008-11-06 | Kikuji Yamaguchi | ヘリコバクター・ピロリ除菌剤 |
Non-Patent Citations (3)
| Title |
|---|
| "Diagnosis and Treatment Guidelines for Helicobacterpylori Infection", 2003, THE JAPANESE SOCIETY FOR HELICOBACTER RESEARCH |
| "Diagnosis and Treatment Guidelines", June 2000, THE JAPANESE SOCIETY FOR HELICOBACTER RESEARCH |
| See also references of EP2351572A4 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016029897A (ja) * | 2014-07-25 | 2016-03-07 | 木村 由美子 | しそ飲料の製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2351572A1 (en) | 2011-08-03 |
| JP5600067B2 (ja) | 2014-10-01 |
| EP2351572B1 (en) | 2018-05-16 |
| CN102215852A (zh) | 2011-10-12 |
| EP2351572A4 (en) | 2014-09-10 |
| CN102215852B (zh) | 2014-06-11 |
| US8658226B2 (en) | 2014-02-25 |
| JPWO2010050583A1 (ja) | 2012-03-29 |
| US20110206791A1 (en) | 2011-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003251197B9 (en) | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | |
| Shaikh et al. | Prospective role in treatment of major illnesses and potential benefits as a safe insecticide and natural food preservative of mint (Mentha spp.): a Review | |
| WO2009153989A1 (ja) | ユーカリ抽出物の調製方法 | |
| JP5110673B2 (ja) | リパーゼ阻害剤 | |
| CN104039329B (zh) | 含去鼠李糖洋丁香酚苷的橄榄提取物 | |
| JP5600067B2 (ja) | 抗ヘリコバクター・ピロリ活性剤 | |
| JP7713295B2 (ja) | 5α-レダクターゼ阻害剤及び前立腺肥大抑制剤 | |
| JP3547835B2 (ja) | 喉炎症・溶血毒の予防・治療剤およびこれを含有する口腔用組成物 | |
| KR101692889B1 (ko) | 두메닥나무 추출물 또는 이의 분획물을 포함하는 염증성 질환의 예방 또는 치료용 조성물 | |
| CN102771850B (zh) | 一种用菊花秸秆制备清凉饮料的方法 | |
| JP4541662B2 (ja) | 抗ピロリ菌組成物 | |
| KR20190101063A (ko) | 천연물질 추출물을 함유하는 기관지 질환 예방 및 개선을 위한 조성물 및 그 제조방법 | |
| JP2006265118A (ja) | アカテツ科植物抽出物を含む抗菌剤および抗菌性組成物 | |
| US11260097B2 (en) | Immunomodulatory composition to treat and/or prevent COVID-19 illness | |
| JP2007131568A (ja) | 免疫賦活剤及びこれを含有する免疫賦活性飲食物 | |
| WO2005046358A1 (ja) | オリーブまんでがん利用法および抗ピロリ菌活性を有する食品 | |
| Idrus | The Role of Sapodilla Fruit on Salmonella Typhi | |
| Sahoo | Antioxidant &antimicrobial efficacy of Ficus religiosa L. & Ficus benghalensis L. PLANT | |
| Coolborn et al. | Hyptis Suaveolens L. Leaf extracts in traditional health care systems | |
| JP2006188442A (ja) | ブナ科植物種子抽出物を含む抗菌剤および抗菌性組成物 | |
| JP2006290794A (ja) | 抗ヘリコバクター・ピロリ活性を有する植物発酵物 | |
| KR20180000144A (ko) | 함초를 이용한 발효추출물의 제조방법 및 이를 이용한 모발용 화장료 조성물 | |
| JP2025032782A (ja) | フラボノイドの吸収促進剤 | |
| JP2024061935A (ja) | プラーク形成抑制剤 | |
| TW201238593A (en) | Anti-inflammatory agent and process of producing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 200980143318.2 Country of ref document: CN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09823693 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010535847 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13126770 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2009823693 Country of ref document: EP |